Search

everythinglearnresearchcommunity

for

Search:↓

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Lowering testosterone speeds up wound healing in male mice.

Lower SHBG levels may increase the risk of PCOS.

Lactococcus lactis strain H61 may reduce some ageing symptoms.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

FFA's causes may include environmental triggers and genetic factors.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Finasteride improves hair density and thickness in women with hair loss.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

SHBG may be a useful early indicator and treatment target for PCOS.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.